-
Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |(R)-3-(Boc-Amino)piperidine |CAS: 309956-78-3 |C10H20N2O2
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |(R)-3-(Boc-Amino)piperidine |CAS: 309956-78-3 |C10H20N2O2
-
![Farmaseutyske grûnstoffen en intermediates |Diabetes |3-(trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |CAS No.762240-92-6](https://www.yisunbio.com/uploads/pgy-Ce1.jpg)
Farmaseutyske grûnstoffen en intermediates |Diabetes |3-(trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |CAS No.762240-92-6
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |3-(trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride|CAS: 762240-92-6
-
Farmaseutyske grûnstoffen en intermediates |Diabetes |Boc-(R)-3-Amino-4-(2,4,5-trifluorfenyl)butanoic acid |CAS No.486460-00-8
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |Boc-(R)-3-Amino-4-(2,4,5-trifluorfenyl)butanoic acid |CAS: 486460-00-8
-
Farmaseutyske grûnstoffen en intermediates |Diabetes |(R)-3-Aminopiperidine dihydrochloride |CAS No.334618-23-4
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |(R)-3-Aminopiperidine dihydrochloride |CAS: 334618-23-4 |C5H14Cl2N2
-
Pharmaceutical Intermediates |(R)-1-Boc-3-Aminopiperidine |Diabetes |CAS: 188111-79-7
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Pharmaceutical Intermediates |(R)-1-Boc-3-Aminopiperidine |CAS:188111-79-7 |C10H20N2O2